1. Neligan, A, Shorvon, SD. Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review. Epilepsy Res. 2011;93(1):1-10.
Google Scholar | Crossref | Medline2. Trinka, E, Cock, H, Hesdorffer, D, et al. A definition and classification of status epilepticus--report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56(10):1515-1523.
Google Scholar | Crossref | Medline3. Rosenow, F, Hamer, HM, Knake, S. The epidemiology of convulsive and nonconvulsive status epilepticus. Epilepsia. 2007;48(Suppl 8):82-84.
Google Scholar | Crossref | Medline4. Rudin, D, Grize, L, Schindler, C, Marsch, S, Rüegg, S, Sutter, R. High prevalence of nonconvulsive and subtle status epilepticus in an ICU of a tertiary care center: a three-year observational cohort study. Epilepsy Res. 2011;96(1–2):140-150.
Google Scholar | Crossref | Medline5. Shneker, BF, Fountain, NB. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology. 2003;61(8):1066-1073.
Google Scholar | Crossref | Medline | ISI6. Hocker, SE, Britton, JW, Mandrekar, JN, Wijdicks, EF, Rabinstein, AA. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2013;70(1):72-77.
Google Scholar | Crossref | Medline7. Sutter, R, Marsch, S, Fuhr, P, Rüegg, S. Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study. Epilepsia. 2013;54(3):502-511.
Google Scholar | Crossref | Medline | ISI8. Santamarina, E, González-Cuevas, GM, Sanchez, A, et al. Prognosis of status epilepticus in patients requiring intravenous anesthetic drugs (a single center experience). Seizure. 2017;45:74-79.
Google Scholar | Crossref | Medline9. Kantanen, AM, Kälviäinen, R, Parviainen, I, Ala-Peijari, M, Bäcklund, T, Koskenkari, J. Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study. Crit Care. 2017;21(1):71.
Google Scholar | Crossref | Medline10. Kantanen, AM, Reinikainen, M, Parviainen, I, Kälviäinen, R. Long-term outcome of refractory status epilepticus in adults: a retrospective population-based study. Epilepsy Res. 2017;133:13-21.
Google Scholar | Crossref | Medline11. Hocker, S . Systemic complications of status epilepticus-An update. Epilepsy Behav. 2015;49:83-87.
Google Scholar | Crossref | Medline12. Sutter, R, Dittrich, T, Semmlack, S, Rüegg, S, Marsch, S, Kaplan, PW. Acute systemic complications of convulsive status epilepticus-A systematic review. Crit Care Med. 2018;46(1):138-145.
Google Scholar | Crossref | Medline13. Hawkes, MA, Hocker, SE. Systemic complications following status epilepticus. Curr Neurol Neurosci Rep. 2018;18(2):7.
Google Scholar | Crossref | Medline14. Kamppi, L, Ritvanen, J, Strbian, D, Mustonen, H, Soinila, S. Complication burden index- A tool for comprehensive evaluation of the effect of complications on functional outcome after status epilepticus. Epilepsia. 2018;59(S2):176-181.
Google Scholar | Crossref | Medline15. Newey, CR, Wisco, D, Nattanmai, P, Sarwal, A. Observed medical and surgical complications of prolonged barbiturate coma for refractory status epilepticus. Ther Adv Drug Saf. 2016;7(5):195-203.
Google Scholar | SAGE Journals | ISI16. Beniczky, S, Hirsch, JL, Kaplan, PW, et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia. 2013;54(Suppl 6):28-29.
Google Scholar | Crossref | Medline17. Power, KN, Flaatten, H, Gilhus, NE, Engelsen, BA. Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome. Epilepsy Res. 2011;94(1–2):53-60.
Google Scholar | Crossref | Medline18. Mayer, SA, Claassen, J, Lokin, J, Mendelsohn, F, Dennis, LJ, Fitzsimmons, BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205-210.
Google Scholar | Crossref | Medline19. Shepherd, S, Batra, A, Lerner, DP. Review of critical illness myopathy and neuropathy. Neurohospitalist. 2017;7(1):41-48.
Google Scholar | SAGE Journals | ISI20. Neuwelt, EA, Kikuchi, K, Hill, SA, Lipsky, P, Frenkel, E. Barbiturate inhibition of lymphocyte function. Differing effects of various barbiturates used to induce coma. J Neurosurg. 1982;56(2):254-259.
Google Scholar | Crossref | Medline21. Kress, HG, Eberlein, T, Hörber, B, Weis, KH. Suppression of neutrophil migration and chemiluminescence is due to the sulphur atom in the thiobarbiturate molecule. Acta Anaesthesiol Scand. 1989;33(2):122-128.
Google Scholar | Crossref | Medline22. Kress, HG, Segmüller, R. Intravenous anesthetics and human neutrophil granulocyte motility in vitro. Anaesthesist. 1987;36(7):356-361.
Google Scholar | Medline23. Vanlersberghe, C, Camu, F. Propofol. Handb Exp Pharmacol. 2008(182):227-252.
Google Scholar | Crossref | Medline24. Li, Y, Tian, L, Zeng, T, Chen, J, Chen, L, Zhou, D. Clinical features and outcome of super-refractory status epilepticus: a retrospective analysis in west China. Seizure. 2014;23(9):722-727.
Google Scholar | Crossref | Medline25. Lai, A, Outin, HD, Jabot, J, et al. Functional outcome of prolonged refractory status epilepticus. Crit Care. 2015;19(1):199.
Google Scholar | Crossref | Medline26. Krumholz, A, Sung, GY, Fisher, RS, Barry, E, Bergey, GK, Grattan, LM. Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology. 1995;45(8):1499-1504.
Google Scholar | Crossref | Medline27. Kowalski, RG, Ziai, WC, Rees, RN, et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med. 2012;40(9):2677-2684.
Google Scholar | Crossref | Medline28. Hawkes, MA, English, SW, Mandrekar, JN, Rabinstein, AA, Hocker, S. Causes of death in status epilepticus. Crit Care Med. 2019;47(9):1226-1231.
Google Scholar | Crossref | Medline29. Sutter, R, Marsch, S, Fuhr, P, Kaplan, PW, Rüegg, S. Anesthetic drugs in status epilepticus: risc or rescue? A 6–year cohort study. Neurology. 2014;82(8):656-664.
Google Scholar | Crossref | Medline | ISI30. Neligan, A, Walker, MC. Falling status epilepticus mortality rates in England and wales: 2001–2013? Epilepsia. 2016;57(7):e121-e124.
Google Scholar | Crossref | Medline31. Muhlhofer, WG, Layfield, S, Lowenstein, D, et al. Duration of therapeutic coma and outcome of refractory status epilepticus. Epilepsia. 2019;60(5):921-934.
Google Scholar | Crossref | Medline